Paper38420192
From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice.
Shubbar Q and 5 others. Front Pharmacol, 2024. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice. Papers, record 38420192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38420192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32506666 | CYP2C19 Allele Frequencies in Over 2.2 Million Direct-to-Consumer Genetics Research Participants and the Potential Implication for Prescriptions in a Large Health System. | Clin Transl Sci | 2020 | https://conductscience.org/library/papers/32506666 | PubMed |
| 2 | 30554109 | Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions? | Psychiatry Res | 2019 | https://conductscience.org/library/papers/30554109 | PubMed |
| 3 | 11454728 | Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. | Drug Metab Dispos | 2001 | https://conductscience.org/library/papers/11454728 | PubMed |
| 4 | 37287029 | Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study. | Hum Genomics | 2023 | https://conductscience.org/library/papers/37287029 | PubMed |
| 5 | 23486447 | Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. | Clin Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23486447 | PubMed |
| 6 | 35156424 | CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. | J Am Heart Assoc | 2022 | https://conductscience.org/library/papers/35156424 | PubMed |
| 7 | 24322971 | Cardiovascular pharmacogenomics: expectations and practical benefits. | Clin Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24322971 | PubMed |
| 8 | 33260705 | Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative. | J Pers Med | 2020 | https://conductscience.org/library/papers/33260705 | PubMed |
| 9 | 35890168 | Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35890168 | PubMed |
| 10 | 30837874 | Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/30837874 | PubMed |
| 11 | 33551797 | Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33551797 | PubMed |
| 12 | 23670120 | Challenges and limitations in the interpretation of systematic reviews: making sense of clopidogrel and CYP2C19 pharmacogenetics. | Clin Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23670120 | PubMed |
| 13 | 27304207 | CYP2C19 and CYP2D6 genotypes in Pacific peoples. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/27304207 | PubMed |
| 14 | 31849282 | Cost-effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome. | Pharmacogenomics | 2020 | https://conductscience.org/library/papers/31849282 | PubMed |
| 15 | 23333322 | Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. | Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23333322 | PubMed |
| 16 | 36333412 | Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder. | Pharmacogenomics J | 2023 | https://conductscience.org/library/papers/36333412 | PubMed |
| 17 | 32572118 | Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia. | Sci Rep | 2020 | https://conductscience.org/library/papers/32572118 | PubMed |
| 18 | 36739136 | A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. | Lancet | 2023 | https://conductscience.org/library/papers/36739136 | PubMed |
| 19 | 37032427 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants. | Clin Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37032427 | PubMed |
| 20 | 20801494 | Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. | Lancet | 2010 | https://conductscience.org/library/papers/20801494 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943264 | Oxidative Susceptibility of Coumarin-1,2,3-Triazole-Isatin Hybrids: Integrating In Silico CYP-Mediated Metabolism Prediction with Electrochemistry-Mass Spectrometry. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943264 | PubMed |
| 42891844 | Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42891844 | PubMed |
| 42836503 | The Role of Exosomal Biomarkers in the Monitoring of Bioactivation and Metabolite Clearance of Chemotherapeutics in Cancer Patients. | Curr Drug Metab | 2026 | https://conductscience.org/library/papers/42836503 | PubMed |
| 42807667 | Pharmacogenomics in the United Arab Emirates: advances in population genomics and challenges in clinical implementation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42807667 | PubMed |
| 42683981 | Distribution of CYP2C19 polymorphism and predicted metabolizer phenotypes in the Indian population: A systematic review. | Indian J Pharmacol | 2026 | https://conductscience.org/library/papers/42683981 | PubMed |
| 42491921 | Impact of UGT1A9 Expression on Analgesic Efficacy and Safety of Postoperative Ketorolac in Thyroid Cancer Surgery: A Prospective Cohort Study. | J Pain Res | 2026 | https://conductscience.org/library/papers/42491921 | PubMed |
| 42445529 | Several antiplatelet gene SNPs, their haplotypes and G × E interactions on premature coronary artery disease. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42445529 | PubMed |
| 42356431 | CYP450 Metabolizer Phenotypes in a Turkish Emergency Cardiac Patient Cohort: A Descriptive Pharmacogenomic Study. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356431 | PubMed |
| 42328638 | Integrating CRISPR functional genomics with admixture-aware psychotropic pharmacogenetics in Brazil. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42328638 | PubMed |
| 42219154 | Evaluation of a pantoprazole and 4-desmethylpantoprazole-sulfate metabolic ratio as a novel CYP2C19 phenotyping method. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42219154 | PubMed |
| 42168535 | Pharmacogenomic landscape of a Moroccan cohort: enhancing global diversity and addressing the North African gap. | Sci Rep | 2026 | https://conductscience.org/library/papers/42168535 | PubMed |
| 42041360 | Targeting Bacterial Infections in Periodontal Disease: From Conventional Antibiotics to Next-Generation Therapeutics. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42041360 | PubMed |
| 42037677 | Clinical efficacy of drug-eluting stents in the treatment of vertebral artery stenosis and analysis of factors contributing to stent restenosis. | Front Neurol | 2026 | https://conductscience.org/library/papers/42037677 | PubMed |
| 41948562 | Type 2 diabetes mellitus as a state of altered drug pharmacokinetic-pharmacodynamic parameters: an update on recent developments and clinical implications. | Ther Adv Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41948562 | PubMed |
| 41803106 | Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants. | Pharmacogenomics J | 2026 | https://conductscience.org/library/papers/41803106 | PubMed |
| 41529816 | Actionable medications in Australian Vietnam War veterans: Implications for pre-emptive pharmacogenetic testing. | Australas Psychiatry | 2026 | https://conductscience.org/library/papers/41529816 | PubMed |
| 41518218 | Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/41518218 | PubMed |
| 41241757 | Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/41241757 | PubMed |
| 41196651 | Implementation of clopidogrel pharmacogenetics: a Brazilian perspective. | Pharmacogenomics | 2025 | https://conductscience.org/library/papers/41196651 | PubMed |
| 41158125 | The impact of the exposome on cytochrome P450-mediated drug metabolism. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41158125 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP2C19 | 1557 | PubTator's text mining | https://conductscience.org/library/genes/1557 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38420192
GET https://conductscience.org/api/papers/v1/38420192/references?page=2